AI’s growing clout in healthcare and pharma and candid confessions from drugmaker CEOs dominated the narrative at JPM 2026.
The change could ease stigma and fuel uptake, especially as oral weight loss drugs hit the market.
It targets pharma margins, PBM fees, and insurance subsidies to slash costs, which could redefine pricing power and consumer choice across the industry.
As funding concentrates among fewer companies, smaller players may need to sharpen differentiation.
Nurses top Gallup’s poll, but trust in clinicians strains under broader healthcare discontent.
As consumer health AI tools expand, companies must tread carefully or risk eroding consumer confidence.
In the crowded clinical market, trusted data, accuracy, and speed will shape adoption.
Weight and health improvements vanish within two years without sustained use, new research finds.
Walmart’s low-risk online health hub could funnel customers to retail and pharmacy without the heavy overhead of primary care.
Drugmakers could ease fears of transactional, unsupervised prescribing by collaborating with patients’ regular care teams.
Its new ChatGPT for Healthcare aims to win over physicians and health systems with HIPAA-safe, evidence-based tools.
Pharma branding agencies are using AI platforms to craft standout drug names while avoiding risk and streamlining time to market.
A new Rx refill program cuts out physicians, raising fears over safety—tougher regulatory oversight is likely to come.
US dietary guidelines overhaul decades of low-fat advice and target added sugar.
ChatGPT Health lets users upload medical data for personalized wellness advice—a feature likely to gain traction as folks trade in data privacy for AI-powered health insights.
News on drugmaker deals, weight loss drug coverage, medication price hikes, and health insurance to kick off the New Year.
AI platforms must tread carefully to avoid crossing into diagnosis and treatment advice
The first oral GLP-1 hits pharmacy shelves and telehealth platforms this week, expanding access to more affordable obesity treatment.
The CDC’s new guidance muddles what’s essential, risking more missed or delayed shots.
AI is moving from novelty to necessity in wellness tech with skin scans, therapy booths, and more.